PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $736,827 | -45.2% | 154,471 | 0.0% | 0.54% | -34.3% |
| Q4 2022 | $1,343,898 | -26.9% | 154,471 | -0.0% | 0.83% | +4.4% |
| Q3 2022 | $1,839,000 | -15.4% | 154,500 | +1.3% | 0.79% | -34.6% |
| Q2 2022 | $2,173,000 | -55.7% | 152,500 | -35.2% | 1.21% | -47.1% |
| Q1 2022 | $4,903,000 | +975.2% | 235,500 | +1599.6% | 2.29% | +1297.0% |
| Q1 2021 | $456,000 | -50.6% | 13,856 | -7.6% | 0.16% | -34.7% |
| Q4 2020 | $923,000 | – | 15,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 4,179,416 | $257,076,000 | 54.42% |
| INTERWEST VENTURE MANAGEMENT CO | 6,469,911 | $397,964,000 | 49.71% |
| Octagon Capital Advisors LP | 250,000 | $15,378,000 | 5.33% |
| Boxer Capital, LLC | 2,268,236 | $139,519,000 | 4.48% |
| COMMODORE CAPITAL LP | 125,000 | $7,689,000 | 4.18% |
| Orbimed Advisors | 7,330,423 | $450,894,000 | 3.95% |
| Asymmetry Capital Management, L.P. | 96,595 | $5,942,000 | 2.71% |
| Avoro Capital Advisors LLC | 2,350,267 | $130,536,000 | 2.25% |
| RA Capital Management | 1,710,265 | $105,198,000 | 1.47% |
| HighVista Strategies LLC | 22,654 | $1,393,000 | 0.89% |